Drawing for TN-CYCLON

USPTO serial 79411335

TN-CYCLON

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
ALI, STEPHANIE MARIE
Law office
TMEG LAW OFFICE 109

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TN-CYCLON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kumiko Ide

Kumiko Ide Wenderoth, Lind & Ponack, L.L.P.1025 Connecticut Avenue NW, Suite 500Washington, DC 20036United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical reagents for scientific purposes; chemical preparations for scientific purposes; diagnostic reagents for scientific or research use; diagnostic reagents and preparations, except for medical or veterinary use; reagents for research purposes; biochemical reagents used for non-medical purposes; reagents for testing and detecting proteins, other than for medical or veterinary purposes; chemical reagents for separating, detecting, measuring and analyzing proteins, other than for medical or veterinary purposes; chemical agents for analyzing proteins, other than for medical or veterinary purposes; chemicals for the manufacture of quasi-drugs; reagents for testing proteins in specimens, other than for medical or veterinary purposes; chemical reagents consisting of antibodies for detecting specific proteins, other than for medical or veterinary purposes; proteins for biotechnology for use in manufacture; proteins for biotechnology, for industrial use; enzymes for biotechnology, for industrial purposesACTIVE—
005Diagnostic biomarker reagents for medical purposes; medical diagnostic reagents; reagents for medical use; diagnostic reagents for medical use; chemical preparations for pharmaceutical or medical purposes for treating cancer, infection diseases, and other clinical diseases; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical and veterinary use; reagents for medical or veterinary purposesACTIVE—
009Laboratory apparatus and instruments for extracting specific target of protein, and antigen not for medical purposes; medical laboratory research instruments for protein/antigen analysis; medical laboratory research instruments for extracting nucleic acids, proteins, or molecules from cells or tissues; medical laboratory research instruments being protein analyzers; laboratory testers being medical laboratory research instruments for testing nucleic acids and proteins; diagnostic apparatus for research laboratory use for measuring the concentration of a specific molecule or compound; medical laboratory research instruments for automatically controlling injection of reagents; medical laboratory research instruments being measuring instruments for detecting proteins; medical laboratory research instruments for automatically controlling injection of reagentsACTIVE—
010Medical diagnostic apparatus for testing DNA and RNA samples; medical diagnostic apparatus for analysing protein; medical diagnostic apparatus for detecting proteinACTIVE—
042Design of protein measuring device for measuring DNA and RNA or protein, for medical and diagnostic purposes; design of protein analyzer for analyzing DNA and RNA or protein, for medical and diagnostic purposes; development of protein detection devices and detection equipment for medical and diagnostic use; design of protein detection devices and detection equipment for medical and diagnostic use; biomedical research services; scientific investigations for medical purposes; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; provision of technological information in the field of pharmaceutical testing, inspection, or research, and consulting related thereto; scientific testing, research or development in the fields of proteins, antibodies, microorganisms and cells; analysis or identification of DNA, RNA or protein for scientific research purposes; testing and research services relating to machines, apparatus and instruments; calibration of measuring apparatus; scientific and medical research and development; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of medical devices and diagnostic reagents; consultancy and research services in the fields of science, engineering and information technology; material testing and analysingACTIVE—
044Medical and pharmaceutical consultation; provision of health care and medical services by health care professionals via the Internet or telecommunication networks; preparation and dispensing of medications; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; rental of medical machines and apparatusACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 21, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 4, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 4, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 3, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 3, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 3, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 21, 2025RFNTREFUSAL PROCESSED BY IB—
Jun 3, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 3, 2025RFRRREFUSAL PROCESSED BY MPU—
Apr 1, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 31, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2024DOCKASSIGNED TO EXAMINER—
Dec 6, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 6, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 5, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance